Pancreatic Cancer Research

ResearcherXinjiang Medical UniversityActive in the last 2 years

Hao Wen

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-7144-220X; OpenAlex author ID A5100622844. Sources: OpenAlex.

Their work

Papers
2 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2014: 1 paper · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: 1 paper

Papers 2

  1. Using two-sample Mendelian randomization to study the causal relationship between BMI and pancreatic cancer and applying bioinformatics methods to identify imp… First author DOI 10.21203/rs.3.rs-4288550/v1↗
  2. Knockdown of OCT4 suppresses the growth and invasion of pancreatic cancer cells through inhibition of the AKT pathway. Co-author DOI 10.3892/mmr.2014.2367↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Zhaoyuan Tang · 1 shared paper, 2024 · strength 0.46
  2. Xin‐Jian Xu · 1 shared paper, 2014 · strength 0.04
  3. Xiyan Wang · 1 shared paper, 2014 · strength 0.04
  4. Qilong Chen · 1 shared paper, 2014 · strength 0.04
  5. Hai Lan Lin · 1 shared paper, 2014 · strength 0.04
  6. Tieying He · 1 shared paper, 2014 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.